Immunogenicity and MuMTV-like antigenicity of human breast cancer tissues.
D000951:Antigens, Neoplasm / Q000032:analysis; D000956:Antigens, Viral / Q000032:analysis; D001943:Breast Neoplasms / Q000276:immunology* / Q000382:microbiology / Q000473:pathology; D002278:Carcinoma in Situ / Q000276:immunology; D002464:Cell Migration Inhibition; D003429:Cross Reactions; D004273:DNA, Neoplasm / Q000032:analysis; D004591:Electrophoresis, Polyacrylamide Gel; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular; D007962:Leukocytes / Q000276:immunology; D008208:Lymphatic System / Q000276:immunology; D008213:Lymphocyte Activation; D008324:Mammary Tumor Virus, Mouse / Q000276:immunology; D012157:Mononuclear Phagocyte System / Q000276:immunology; D009363:Neoplasm Proteins / Q000032:analysis; D009693:Nucleic Acid Hybridization; D011379:Prognosis; D012367:RNA, Viral / Q000032:analysis; D012884:Skin Window Technique; D014764:Viral Proteins / Q000032:analysis
D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D012367:RNA, Viral; D014764:Viral Proteins